{"id":"NCT00090142","sponsor":"Organon and Co","briefTitle":"Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)","officialTitle":"A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-05","primaryCompletion":"2004-10","completion":"2004-10","firstPosted":"2004-08-26","resultsPosted":"2010-10-29","lastUpdate":"2022-02-02"},"enrollment":62,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Asthma, Exercise-Induced"],"interventions":[{"type":"DRUG","name":"Comparator: Montelukast","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.","primaryOutcome":{"measure":"Maximum Percent Fall in FEV1 After Exercise Challenge at 2 Hours Post-dose Compared With Pre-exercise Baseline in Patients With Exercise-induced Bronchospasm (EIB)","timeFrame":"Pre-exercise baseline measurement and 0-60 minutes after the exercise challenge performed 2 hours after a single oral dose","effectByArm":[{"arm":"Placebo","deltaMin":17.5,"sd":13.82},{"arm":"Montelukast 10 mg","deltaMin":11.7,"sd":10.8}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["17454341"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":58},"commonTop":["Headache"]}}